abstract |
CHARACTERIZED BECAUSE IT INCLUDES a) AN INSULIN SENSITIZER SUCH AS 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] -BENCIL] THIAZOLIDINE-2,4-DIONA USING 2 mg A 12 mg, OR TROGLITAZONA, CIGLITAZONA, PIOGLITAZONA, ENGLITAZONA AND b) AN ALPHA-GLUCOSIDASE ANTI-HYPERGLUCEMIC AGENT SUCH AS ACARBOSE, EMIGLITATE OR MIGLITOL. THE COMPOSITION MAY BE USEFUL FOR THE TREATMENT OF DIABETES MELLITUS AND FOR THE CONDITIONS ASSOCIATED WITH DIABETES MELLITUS |